Dongwha Pharm.Co.,Ltd (KRX:000020)
5,420.00
-50.00 (-0.91%)
Last updated: Jun 4, 2026, 2:24 PM KST
Dongwha Pharm.Co.,Ltd Market Cap
Dongwha Pharm.Co.,Ltd has a market cap or net worth of 151.62 billion as of June 3, 2026. Its market cap has decreased by -13.04% in one year.
Market Cap
151.62B
Enterprise Value
278.28B
Revenue
501.33B
Ranking
n/a
PE Ratio
7.64
Stock Price
5,420.00
Market Cap Chart
Since August 28, 1995, Dongwha Pharm.Co.,Ltd's market cap has increased from 72.32B to 151.62B, an increase of 109.63%. That is a compound annual growth rate of 2.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 151.62B | -12.48% |
| Dec 30, 2025 | 173.24B | -0.79% |
| Dec 30, 2024 | 174.62B | -38.57% |
| Dec 28, 2023 | 284.26B | 10.91% |
| Dec 29, 2022 | 256.31B | -36.58% |
| Dec 30, 2021 | 404.12B | -25.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CMG Pharmaceutical | 175.93B |
| JW Lifescience | 172.50B |
| HLB Pharmaceutical | 170.47B |
| Hana Pharm | 166.35B |
| Jeil Pharmaceutical Co.,Ltd | 165.68B |
| AptaBio Therapeutics | 156.48B |
| Daihan Pharmaceutical | 154.94B |
| Samil Pharmaceutical Co.,Ltd | 154.13B |